Graves’ eye disease is known as thyroid eye disease. The University of Michigan Kellogg Eye Center is working on an investigational therapy that might not only improve inflammation conditions but also lessen the severity and offer a new patient outcome. The University...
Ophthalmology
Category
Premark Pharma Licenses Investigational Blepharitis Treatment from Novartis
Premark Pharma announced today the completion of a licensing deal with Novartis. Both based in Switzerland, Premark Pharma secured the exclusive worldwide rights to develop and commercialize PMP20207, an ophthalmic ointment formulation, as a potential treatment for...
University of Hong Kong Launches AI-Driven Medical Studies
The University of Hong Kong (HKUMed) launches its Medical Artificial Intelligence Laboratory Programme (MAIL) to pilot an artificial intelligence (AI) healthcare research study through a series of innovative and prospective clinical AI trial. HKU will collaborate with...
The Centre for Eye Research Australia Fast Tracking World’s First Eye Tracking Alzheimer’s Detection Study
The Centre for Eye Research Australia (CERA) received $600,00 from American philanthropists including Bill Gates and MacKenzie Bezos. The Melbourne, Australia group has developed a non-invasive, cost effective eye test to detect early signs of Alzheimer’s disease. By...
Altos Eye Physicians of Los Altos CA Participates in the IC-8 Lens Study
Cataracts are a leading cause of vision loss over 40 but they are treatable. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single focus) lens, enabling the...
University of Illinois Leads Clinical Trial for New Severe Dry Eye Treatment
The University of Illinois at Chicago is leading a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a recent paper published in Translational Vision Science and...
Lutronic Signs Renowned Univ. of Melbourne Investigator Robyn Guymer
Robyn Guymer based in Australia, is a world-renowned retinal disease specialist with extensive clinical experience in Age-related macular degeneration (AMD). Dr. Guymer was one of the first to define nascent geography atrophy through OCT. Lutronic Vision (Lutronic)...
Kugler Vision Participates in the AcuFocus Vision Clinical Trial
Kugler Vision dedicated to better vision is participating in the AcuFocus clinical trial for the IC-8 intraocular lens (IOL) designed for patients with cataracts. Dr. Lance Kugler, a prominent investigator notes “we work with cataract patients each day and many ask if...
Osaka University Approves IPS Linked Clinical Trial for Corneal Damage
Osaka University Japan obtained approval for a planned clinical trial focusing on a method to treat patients with a damaged cornea by transplanting cells made from induced pluripotent stem cells (iPS) from other people. iPS cells are a type of pluripotent stem...
St. Michael’s Hospital Study Shows Minimally Invasive Retinal Detachment Treatment Superior Outcomes
As reported in Science Daily, a minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital in Toronto. Lead...
Icahn School of Medicine Ted Smith Discusses Advancements in Retina Space
Michaela Fleming writing for MDMag provides an overview of Dr. Ted Smith, professor of ophthalmology at Icahn School of Medicine at Mount Sinai presenting his research on hyperspectral autofluorescence imaging of AMD later this weekend in a presentation at the...
Euro Medicines Agency Accepts Application for Aerie Pharmaceuticals Drug
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the...
Medical University of Vienna: AI in Ophthalmology
Around six years ago, high-resolution optical coherence tomography (OCT) was jointly developed by MedUni Vienna's Center for Medical Physics and Biomedical Technology and its Department of Ophthalmology. OCT is an imaging technique that, like ultrasound – but...
Hirschfield, Jeffrey A MD
Jeffrey A Hirschfield, MDSCORE Physician Alliance LLCThe Pediatric NetworkSt. Petersburg, FL Therapeutic Area: Primary Care, Dermatology, Pulmonology, Ob/Gyn, Infectious Disease, Oncology, and Opthalmology Sub-specialties Associated Articles
Dutch Study: OCT May Detect Biomarkers for Dementia, Alzheimer’s Disease
Thinner retinal nerve fiber may be a biomarker for dementia. See study Research/Investigative Sites Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands. Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands....
Clinical Outcomes Following Trifocal Diffractive Intraocular Lens Implantation for Age-related Cataract in China
Peking University Third Hospital— In this study, the trifocal diffractive IOL provided excellent visual performance at all distances and improved contrast sensitivity under different conditions, resulting in elevated levels of patient satisfaction and spectacle...
Researchers Implement Predictive Screening Tool for Retinopathy in Premature Infants
ROP, an eye disorder can lead to blindness. The disorder leads to blindness in 400 to 600 infants per year in the United States. The National Eye Institute reports that ROP may account for 60 percent of all childhood blindness in some parts of the world. To reduce...
More Than 450 Million Chinese Myopic
"The myopia rates are around 30 percent for primary school students" To view article click here